Arrhythmogenic Right Ventricular Cardiomyopathy: Difference between revisions

Arrhythmogenic Right Ventricular Cardiomyopathy (view source)

Revision as of 00:05, 28 January 2010

No change in size , 28 January 2010

no edit summary

KGoldin

114

edits

@@ Line 42: / Line 42: @@
 '''Treatment''' focuses on avoiding complications.<cite>ACC2006</cite>
 *Medication:
-**anti-arrhythmics: Sotalol better than Amiodarone.
+**Anti-arrhythmics: Sotalol better than Amiodarone.
 **ACE-inhibitors to prevent cardiac remodelling
 *[[ICD]] implantation is recommended for the prevention of sudden cardiac death in patients with ARVC with documented sustained VT or VF who are receiving chronic optimal medical therapy.
-*[[ICD]]] implantation can be considered for the prevention of sudden cardiac death in patients with ARVC with extensive disease, including those with left ventricular involvement, 1 or more affected family member with SCD, or undiagnosed syncope when [[Ventricular Tachycardia|ventricular tachycardia]] or [[Ventricular Fibrillation|ventricular Fibrillation]] has not been excluded as the cause of syncope, who are receiving chronic optimal medical therapy, and who have reasonable expectation of survival with a good functional status for more than 1 y.
+*[[ICD]]] implantation can be considered for the prevention of sudden cardiac death in patients with ARVC with extensive disease, including those with left ventricular involvement, 1 or more affected family member with ICD, or undiagnosed syncope when [[Ventricular Tachycardia|ventricular tachycardia]] or [[Ventricular Fibrillation|ventricular Fibrillation]] has not been excluded as the cause of syncope, who are receiving chronic optimal medical therapy, and who have reasonable expectation of survival with a good functional status for more than 1 y.
 *Radiofrequency [[ablation]] can be useful as adjunctive therapy in management of patients with ARVC with recurrent [[Ventricular Tachycardia|ventricular tachycardia]], despite optimal antiarrhythmic drug therapy.